Cargando…
Cannabinoids for fibromyalgia pain: a critical review of recent studies (2015–2019)
INTRODUCTION: Fibromyalgia is a chronic health condition characterized by widespread, severe musculoskeletal pain that affects an estimated 5–7% of the global population. Due to the highly comorbid nature of fibromyalgia, patients with the disorder often respond poorly to traditional pain treatments...
Autores principales: | Cameron, Erinn C., Hemingway, Samantha L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7819299/ https://www.ncbi.nlm.nih.gov/pubmed/33526114 http://dx.doi.org/10.1186/s42238-020-00024-2 |
Ejemplares similares
-
Recent data on cannabinoids and their pharmacological implications in neuropathic pain
por: Oana, Andreia Coman, et al.
Publicado: (2008) -
Biology and therapy of fibromyalgia: pain in fibromyalgia syndrome
por: Staud, Roland
Publicado: (2006) -
Beyond pain in fibromyalgia: insights into the symptom of fatigue
por: Vincent, Ann, et al.
Publicado: (2013) -
Diagnostic Criteria for Fibromyalgia: Critical Review and Future Perspectives
por: Galvez-Sánchez, Carmen M., et al.
Publicado: (2020) -
Recent advances in endometrial cancer: a review of key clinical trials from 2015 to 2019
por: Charo, Lindsey M., et al.
Publicado: (2019)